Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 52 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 113 | 4,671−4.3%/yr | −4.3%/yr | 2.50.9× | 3% | 4,720 in 2030+0.2%/yr |
| Lumbar fusion | 96 | 3,407−0.3%/yr | −0.3%/yr | 1.80.8× | 1% | 4,050 in 2030+2.9%/yr |
| Cervical fusion & disc arthroplasty | 35 | 1,875−1.6%/yr | −1.6%/yr | 1.00.9× | 2% | 1,980 in 2030+0.9%/yr |
| Kyphoplasty & vertebroplasty | 12 | 1,432−3.1%/yr | −3.1%/yr | 0.80.9× | 29% | 1,740 in 2030+3.3%/yr |
| SI joint fusion | 0 | 175+8.8%/yr | +8.8%/yr | 0.10.7× | 0% | 450 in 2030+17%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 877 | 165,137−3.1%/yr | −3.1%/yr | 86.31.0× | 54% | 176,500 in 2030+1.1%/yr |
| Skin substitutes & wound grafts | 70 | 14,481+3.3%/yr | +3.3%/yr | 4.70.9× | 45% | 20,500 in 2030+5.9%/yr |
| Bone graft & orthobiologics | 21 | 796−5%/yr | −5%/yr | 0.40.9× | 1% | 810 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 223 | 14,264−0.1%/yr | −0.1%/yr | 7.51.0× | 81% | 18,300 in 2030+4.2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 22 | 1,267+7.6%/yr | +7.6%/yr | 0.60.9× | 39% | 2,170 in 2030+9.4%/yr |
| Spinal cord & DRG stimulation | 12 | 563−6.5%/yr | −6.5%/yr | 0.30.7× | 16% | 550 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 109 | 13,452−13%/yr | −13%/yr | 7.71.7× | 80% | 12,500 in 2030−1.2%/yr |
| Peripheral arterial intervention | 97 | 12,468−0.1%/yr | −0.1%/yr | 6.51.5× | 60% | 16,300 in 2030+4.6%/yr |
| Superficial venous ablation | 132 | 8,630−5.2%/yr | −5.2%/yr | 4.51.6× | 97% | 9,880 in 2030+2.3%/yr |
| Thrombectomy, IVC filters & venous stents | 24 | 2,696−2.3%/yr | −2.3%/yr | 1.51.2× | 17% | 3,720 in 2030+5.5%/yr |
| Carotid revascularization | 32 | 1,508−6.4%/yr | −6.4%/yr | 0.80.7× | 0% | 1,510 in 20300%/yr |
| Aortic endografts (EVAR/TEVAR) | 7 | 818−5.7%/yr | −5.7%/yr | 0.51.1× | 0% | 860 in 2030+0.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 131 | 10,502−1.8%/yr | −1.8%/yr | 6.11.0× | 7% | 11,800 in 2030+1.9%/yr |
| Cholecystectomy & appendectomy | 96 | 5,762−3.7%/yr | −3.7%/yr | 3.30.9× | 2% | 6,020 in 2030+0.7%/yr |
| Colorectal resection | 15 | 2,669−5%/yr | −5%/yr | 1.50.9× | 0% | 2,770 in 2030+0.6%/yr |
| Breast reconstruction | 6 | 970−6.9%/yr | −6.9%/yr | 0.51.5× | 7% | 1,170 in 2030+3.2%/yr |
| Antireflux & hiatal hernia surgery | 15 | 966−1.7%/yr | −1.7%/yr | 0.50.8× | 0% | 1,220 in 2030+4%/yr |
| Bariatric surgery | 0 | 318−18%/yr | −18%/yr | 0.21.0× | 0% | 200 in 2030−7.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 98 | 8,386−6.8%/yr | −6.8%/yr | 4.61.1× | 43% | 8,420 in 2030+0.1%/yr |
| Kidney stone management | 134 | 7,123−2.3%/yr | −2.3%/yr | 4.00.6× | 10% | 7,020 in 2030−0.2%/yr |
| Hysterectomy, hysteroscopy & ablation | 75 | 6,108−0.3%/yr | −0.3%/yr | 3.71.1× | 30% | 6,960 in 2030+2.2%/yr |
| Incontinence, prolapse & sacral neuromodulation | 38 | 3,138−0.8%/yr | −0.8%/yr | 1.70.9× | 8% | 3,860 in 2030+3.5%/yr |
| Prostatectomy & nephrectomy | 33 | 2,271−2.4%/yr | −2.4%/yr | 1.41.3× | 0% | 2,710 in 2030+3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 61 | 6,979−3.8%/yr | −3.8%/yr | 3.91.2× | 89% | 7,410 in 2030+1%/yr |
| Ear tubes & middle ear surgery | 2 | 294−9%/yr | −9%/yr | 0.20.6× | 17% | 260 in 2030−2.2%/yr |
| Cochlear implants | 3 | 178+1.2%/yr | +1.2%/yr | 0.11.1× | 0% | 160 in 2030−1.7%/yr |
| Sleep apnea & airway implants | 2 | 146+38%/yr | +38%/yr | 0.10.6× | 19% | 160 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 288 | 16,847+0.4%/yr | +0.4%/yr | 9.91.3× | 43% | 18,000 in 2030+1.1%/yr |
| Tumor & fibroid embolization | 22 | 1,661+10%/yr | +10%/yr | 0.91.9× | 48% | 3,360 in 2030+12%/yr |
| Tumor ablation | 3 | 512+0.8%/yr | +0.8%/yr | 0.31.0× | 0% | 600 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 496 | 58,834+16%/yr | +16%/yr | 31.71.1× | 89% | 98,600 in 2030+9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| LAA occlusion & loop recorders | 191 | 8,988+5.9%/yr | +5.9%/yr | 4.31.5× | 12% | 14,400 in 2030+8.1%/yr |
| Pacemaker, ICD & CRT implantation | 148 | 8,138−3%/yr | −3%/yr | 4.70.9× | 0% | 8,390 in 2030+0.5%/yr |
| EP ablation | 138 | 7,854+9.3%/yr | +9.3%/yr | 3.61.2× | 0% | 15,300 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 245 | 13,378−4.1%/yr | −4.1%/yr | 5.91.3× | 0% | 13,900 in 2030+0.6%/yr |
| Structural heart (TAVR, TEER) | 150 | 4,552+1.5%/yr | +1.5%/yr | 2.11.3× | 0% | 6,000 in 2030+4.7%/yr |
| Mechanical circulatory support | 4 | 1,076−3%/yr | −3%/yr | 0.61.1× | 0% | 1,080 in 2030+0.1%/yr |
| PFO & septal closure | 2 | 153+0.3%/yr | +0.3%/yr | 0.11.3× | 0% | 150 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Aneurysm & intracranial embolization | 25 | 1,148+12%/yr | +12%/yr | 0.61.3× | 0% | 1,980 in 2030+9.5%/yr |
| Stroke thrombectomy | 16 | 669+0.8%/yr | +0.8%/yr | 0.40.8× | 0% | 800 in 2030+3%/yr |
| CSF shunts | 6 | 455−4%/yr | −4%/yr | 0.21.4× | 0% | 600 in 2030+4.8%/yr |
| DBS & VNS | 8 | 452−3.8%/yr | −3.8%/yr | 0.20.9× | 0% | 480 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 588 | 82,565−2.7%/yr | −2.7%/yr | 44.50.9× | 75% | 85,900 in 2030+0.7%/yr |
| Vitreoretinal surgery | 42 | 3,504−3.3%/yr | −3.3%/yr | 1.91.0× | 48% | 3,660 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 1,378 | 235,327−1.7%/yr | −1.7%/yr | 134.51.1× | 54% | 246,900 in 2030+0.8%/yr |
| ERCP & endoscopic ultrasound | 101 | 6,049−4.1%/yr | −4.1%/yr | 3.40.9× | 1% | 6,420 in 2030+1%/yr |
| Bronchoscopy & lung nodule | 82 | 4,973+1.9%/yr | +1.9%/yr | 2.80.9× | 0% | 7,320 in 2030+6.6%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.